Dark | Light
# Vertex Pharmaceuticals Incorporated (VRTX)

Vertex Pharmaceuticals (VRTX) reports strong Q4 earnings with revenue up 10% and provides optimistic [----] guidance, while Casgevy sales show accelerated uptake, driving positive sentiment.

### About Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals is a biopharmaceutical company focused on developing medicines for serious diseases.  
Vertex Pharmaceuticals Incorporated uses the ticker $VRTX for trading. Listed in the [Stocks](/list/stocks) category within the [Healthcare](/list/stocks/healthcare) sectors.

### Insights
- Vertex Pharmaceuticals Incorporated (VRTX) trading volume is up 75.26% from the previous week.
- Vertex Pharmaceuticals Incorporated (VRTX) social dominance is up 292.06% from the previous week.
- Vertex Pharmaceuticals Incorporated (VRTX) Galaxy Score™ is up 35.9% from the previous week.
- Vertex Pharmaceuticals Incorporated (VRTX) sentiment is up 41.94% from the previous week.
- Vertex Pharmaceuticals Incorporated (VRTX) engagements is up 244.92% from the previous week.
- Vertex Pharmaceuticals Incorporated (VRTX) mentions is up 46.24% from the previous month.
- Vertex Pharmaceuticals Incorporated (VRTX) posts created is up 120.75% from the previous week.

### Price: $491.50
![Price Line Chart](https://lunarcrush.com/gi/w:600/t:vertex-pharma/c:line/m:close/iv:1d.svg)  
[Price 24-Hour Time-Series Raw Data](/topic/vertex-pharma/time-series/close.tsv)  
Despite a recent dip, positive social sentiment, strong earnings reports, and analyst upgrades suggest a temporary dip before a potential increase.  

24-Hour: 6.35%
7-Day: 3.26%
30-Day: 11.35%

1-Year High: $513.80 on 2025-03-17  
1-Year Low: $366.50 on 2025-08-08  
  
  
### AltRank: [---]
![AltRank Line Chart](https://lunarcrush.com/gi/w:600/t:vertex-pharma/c:line/m:alt_rank/iv:1d.svg)  
[AltRank 24-Hour Time-Series Raw Data](/topic/vertex-pharma/time-series/alt_rank.tsv)  
Vertex Pharmaceuticals Incorporated (VRTX) is currently AltRank #477 based on combined combined social and market metrics
Daily Average: [---]  
[--] Week: [---] +405  
[--] Month: [---] [----]  
[--] Months: [---] [---]  
[--] Year: [---] +147  
1-Year High: [-----] on 2025-07-12  
1-Year Low: [--] on 2025-05-31  
  
  
### Galaxy Score: [-----]
![Galaxy Score Line Chart](https://lunarcrush.com/gi/w:600/t:vertex-pharma/c:line/m:galaxy_score/iv:1d.svg)  
[Galaxy Score 24-Hour Time-Series Raw Data](/topic/vertex-pharma/time-series/galaxy_score.tsv)  
Current Value: [-----]  
Daily Average: [--]  
[--] Week: [--] +14  
[--] Month: [--] [---]  
[--] Months: [--] [---]  
[--] Year: [--] +10  
1-Year High: [--] on 2025-03-03  
1-Year Low: [--] on 2025-09-14  
  
  
### Engagements: [------] (24h)
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/t:vertex-pharma/c:line/m:interactions/iv:1d.svg)  
[Engagements 24-Hour Time-Series Raw Data](/topic/vertex-pharma/time-series/interactions.tsv)  
Current Value: [------]  
Daily Average: [------]  
[--] Week: [-------] +245%  
[--] Month: [-------] +85%  
[--] Months: [---------] -51%  
[--] Year: [----------] -43%  
1-Year High: [-------] on 2025-08-05  
1-Year Low: [-----] on 2025-12-26  

Engagements by network (24h):
Reddit: [--]
TikTok: [--]
YouTube: [--]
X: [------]

  
  
### Mentions: [---] (24h)
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/t:vertex-pharma/c:line/m:posts_active/iv:1d.svg)  
[Mentions 24-Hour Time-Series Raw Data](/topic/vertex-pharma/time-series/posts_active.tsv)  
Current Value: [---]  
Daily Average: [---]  
[--] Week: [---] +26%  
[--] Month: [-----] +46%  
[--] Months: [------] -13%  
[--] Year: [------] +8.50%  
1-Year High: [---] on 2025-06-27  
1-Year Low: [--] on 2025-12-21  

Mentions by network (24h):
Reddit: [--]
TikTok: [--]
YouTube: [--]
X: [---]

  
  
### Creators: [---] (24h)
![Creators Line Chart](https://lunarcrush.com/gi/w:600/t:vertex-pharma/c:line/m:contributors_active/iv:1d.svg)  
[Creators 24-Hour Time-Series Raw Data](/topic/vertex-pharma/time-series/contributors_active.tsv)  
[---] unique social accounts have posts mentioning Vertex Pharmaceuticals Incorporated (VRTX) in the last [--] hours which is down 0.84% from [---] in the previous [--] hours
Daily Average: [---]  
[--] Week: [---] +7.10%  
[--] Month: [---] +35%  
[--] Months: [-----] +2.30%  
[--] Year: [-----] +59%  
1-Year High: [---] on 2025-06-27  
1-Year Low: [--] on 2025-12-21  

The most influential creators that mention Vertex Pharmaceuticals Incorporated in the last [--] hours

| Creator                                            | Rank | Followers | Posts | Engagements |
| -------                                            | ---- | --------- | ----- | ----------- |
| [@OracleEarnings](/creator/twitter/OracleEarnings) | [--]    | [------]    | [--]     | [---]         |
| [@semodough](/creator/twitter/semodough)           | [--]    | [------]    | [--]     | [---]         |
| [@RNAiAnalyst](/creator/twitter/RNAiAnalyst)       | [--]    | [------]    | [--]     | [---]         |
| [@WJones_Global](/creator/twitter/WJones_Global)   | [--]    | [---]       | [--]     | [---]         |
| [@AIStockSavvy](/creator/twitter/AIStockSavvy)     | [--]    | [------]    | [--]     | [---]         |
| [@tenet_research](/creator/twitter/tenet_research) | [--]    | [-------]   | [--]     | [---]         |
| [@doepke_michel](/creator/twitter/doepke_michel)   | [--]    | [-----]     | [--]     | [---]         |
| [@somoscdi](/creator/twitter/somoscdi)             | [--]    | [------]    | [--]     | [---]         |
| [@MarcJacksonLA](/creator/twitter/MarcJacksonLA)   | [--]    | [-----]     | [--]     | [---]         |
| [@HedgeFundTips](/creator/twitter/HedgeFundTips)   | [--]   | [------]    | [--]     | [---]         |

[View More](/list/creators/vertex-pharma/100)
  
  
### Sentiment: 72%
![Sentiment Line Chart](https://lunarcrush.com/gi/w:600/t:vertex-pharma/c:line/m:sentiment/iv:1d.svg)  
[Sentiment 24-Hour Time-Series Raw Data](/topic/vertex-pharma/time-series/sentiment.tsv)  
Current Value: 72%  
Daily Average: 71%  
[--] Week: 88% +26%  
[--] Month: 61% -6%  
[--] Months: 61% -9%  
[--] Year: 61% -18%  
1-Year High: 97% on 2025-07-18  
1-Year Low: 44% on 2025-05-03  

Most Supportive Themes:
- Bullish Sentiment and Price Predictions: (45%) Users are expressing optimism about VRTX's future performance and predicting price increases.
- Positive News and Partnerships: (25%) Recent developments such as reimbursement agreements and new collaborations are contributing to positive sentiment.
- Technical Analysis and Chart Patterns: (15%) Analysis of VRTX's stock chart indicates bullish patterns, suggesting a potential upward trend.
  
Most Critical Themes:
- Market Volatility: (10%) General concerns about the broader market's fluctuations and potential price corrections are present.
- Token Closure Concerns: (5%) Some discussion revolves around the closure of a token, leading to negative sentiment.
  
  
  
### Social Dominance: 0.03%
![Social Dominance Line Chart](https://lunarcrush.com/gi/w:600/t:vertex-pharma/c:line/m:social_dominance/iv:1d.svg)  
[Social Dominance 24-Hour Time-Series Raw Data](/topic/vertex-pharma/time-series/social_dominance.tsv)  
Current Value: 0.03%  
Daily Average: 0.047%  
[--] Week: 0.025% +0.018%  
[--] Month: 0.056% +0.027%  
[--] Months: 0.056% -0.0051%  
[--] Year: 0.056% -0.027%  
1-Year High: 0.136% on 2025-03-12  
1-Year Low: 0.015% on 2025-12-21  
  
  
### Market Dominance: 0.142%
![Market Dominance Line Chart](https://lunarcrush.com/gi/w:600/t:vertex-pharma/c:line/m:market_dominance/iv:1d.svg)  
[Market Dominance 24-Hour Time-Series Raw Data](/topic/vertex-pharma/time-series/market_dominance.tsv)  
Current Value: 0.142%  
Daily Average: 4%  
1-Year High: 5.60% on 2026-02-06  
1-Year Low: 0.142% on 2026-02-14  
  
  
### Market Cap: $125,479,413,406
![Market Cap Line Chart](https://lunarcrush.com/gi/w:600/t:vertex-pharma/c:line/m:market_cap/iv:1d.svg)  
[Market Cap 24-Hour Time-Series Raw Data](/topic/vertex-pharma/time-series/market_cap.tsv)  
Current Value: $125,479,413,406  
Daily Average: $114,185,675,807  
[--] Week: $125,479,413,406 +4.10%  
[--] Month: $124,695,193,872 +11%  
[--] Months: $124,695,193,872 +24%  
[--] Year: $124,695,193,872 +5.80%  
1-Year High: $131,932,122,793 on 2025-03-17  
1-Year Low: $93,977,429,218 on 2025-08-08  

### Top Vertex Pharmaceuticals Incorporated Social Posts
Top posts by engagements in the last [--] hours

*Showing a maximum of [--] top social posts without a LunarCrush subscription.*

"@Investingcom For long-term biotech holds consider $REGN with diversified pipeline beyond Eylea or $VRTX with cystic fibrosis dominance expanding into new indications"  
[X Link](https://x.com/PharmaAlerts/status/2022744046763151640) [@PharmaAlerts](/creator/x/PharmaAlerts) 2026-02-14T18:45Z [---] followers, [---] engagements


"$MSTR 126% wild spike from bottom entry $AMD $NVDA $SMH $TSM $INTC $SPY $QQQ $BTC $ETH $MSTR $MARA $RIOT $HUT $AMAT $CRWD $LI $RIVN $NIO $COIN $AVGO $DOGE $AMC $CVNA $ASML $ADI $AMC $GME $SMCI $VRTX $LOVE $LLY $MELI $TQQQ $SPX $SWTX $ $tSLA 417% Ill rest my case here $AMD $NVDA $SMH $TSM $INTC $SPY $QQQ $BTC $ETH $MSTR $MARA $RIOT $HUT $AMAT $CRWD $LI $RIVN $NIO $COIN $AVGO $DOGE $AMC $CVNA $ASML $ADI $AMC $GME $SMCI $VRTX $LOVE $LLY $MELI $TQQQ $SPX $SWTX $ https://t.co/VxP7hrHqe0 $tSLA 417% Ill rest my case here $AMD $NVDA $SMH $TSM $INTC $SPY $QQQ $BTC $ETH $MSTR $MARA $RIOT $HUT $AMAT"  
[X Link](https://x.com/sMoontrade/status/2022733806747423150) [@sMoontrade](/creator/x/sMoontrade) 2026-02-14T18:04Z [---] followers, [---] engagements


"forward p/e 2/13 yahoo finance $FIX [-----] $FTAI [-----] $STT [-----] $TDY [-----] $Q [-----] $NVT [-----] $ENTG [-----] $MTSI [-----] $AKAM [-----] $KRMN [------] $NVMI [-----] $DY [-----] $SOLS [-----] $VRTX [-----] $MOD [-----] $STRL [-----] $AEIS [-----] $SWKS [-----] $QRVO [-----] $POWL 38.31"  
[X Link](https://x.com/yukkeyo/status/2022687846872814072) [@yukkeyo](/creator/x/yukkeyo) 2026-02-14T15:02Z [---] followers, [---] engagements


"If I am right and the new $RIG can generate $3B of annual free cash flow in a base case and $46B in an optimistic case a rerating is possible. There are not many companies in the world that can produce that level of free cash flow. Look at $UBER $AMT $AMD $VRTX $MMM. They trade between $90B and $300B market caps. But offshore is hated. It cannot get premium multiples. I think that is fine. On the Q3 [----] earnings call the CFO said: Once leverage is reduced management intends to return capital primarily through share repurchases rather than dividends. A lower multiple means they can buy back"  
[X Link](https://x.com/cannibalstocks/status/2022570081058713951) [@cannibalstocks](/creator/x/cannibalstocks) 2026-02-14T07:14Z [---] followers, [----] engagements

Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing

Vertex Pharmaceuticals Incorporated (VRTX)

Vertex Pharmaceuticals (VRTX) reports strong Q4 earnings with revenue up 10% and provides optimistic [----] guidance, while Casgevy sales show accelerated uptake, driving positive sentiment.

About Vertex Pharmaceuticals Incorporated

Vertex Pharmaceuticals is a biopharmaceutical company focused on developing medicines for serious diseases.
Vertex Pharmaceuticals Incorporated uses the ticker $VRTX for trading. Listed in the Stocks category within the Healthcare sectors.

Insights

  • Vertex Pharmaceuticals Incorporated (VRTX) trading volume is up 75.26% from the previous week.
  • Vertex Pharmaceuticals Incorporated (VRTX) social dominance is up 292.06% from the previous week.
  • Vertex Pharmaceuticals Incorporated (VRTX) Galaxy Score™ is up 35.9% from the previous week.
  • Vertex Pharmaceuticals Incorporated (VRTX) sentiment is up 41.94% from the previous week.
  • Vertex Pharmaceuticals Incorporated (VRTX) engagements is up 244.92% from the previous week.
  • Vertex Pharmaceuticals Incorporated (VRTX) mentions is up 46.24% from the previous month.
  • Vertex Pharmaceuticals Incorporated (VRTX) posts created is up 120.75% from the previous week.

Price: $491.50

Price Line Chart
Price 24-Hour Time-Series Raw Data
Despite a recent dip, positive social sentiment, strong earnings reports, and analyst upgrades suggest a temporary dip before a potential increase.

24-Hour: 6.35% 7-Day: 3.26% 30-Day: 11.35%

1-Year High: $513.80 on 2025-03-17
1-Year Low: $366.50 on 2025-08-08

AltRank: [---]

AltRank Line Chart
AltRank 24-Hour Time-Series Raw Data
Vertex Pharmaceuticals Incorporated (VRTX) is currently AltRank #477 based on combined combined social and market metrics Daily Average: [---]
[--] Week: [---] +405
[--] Month: [---] [----]
[--] Months: [---] [---]
[--] Year: [---] +147
1-Year High: [-----] on 2025-07-12
1-Year Low: [--] on 2025-05-31

Galaxy Score: [-----]

Galaxy Score Line Chart
Galaxy Score 24-Hour Time-Series Raw Data
Current Value: [-----]
Daily Average: [--]
[--] Week: [--] +14
[--] Month: [--] [---]
[--] Months: [--] [---]
[--] Year: [--] +10
1-Year High: [--] on 2025-03-03
1-Year Low: [--] on 2025-09-14

Engagements: [------] (24h)

Engagements Line Chart
Engagements 24-Hour Time-Series Raw Data
Current Value: [------]
Daily Average: [------]
[--] Week: [-------] +245%
[--] Month: [-------] +85%
[--] Months: [---------] -51%
[--] Year: [----------] -43%
1-Year High: [-------] on 2025-08-05
1-Year Low: [-----] on 2025-12-26

Engagements by network (24h): Reddit: [--] TikTok: [--] YouTube: [--] X: [------]

Mentions: [---] (24h)

Mentions Line Chart
Mentions 24-Hour Time-Series Raw Data
Current Value: [---]
Daily Average: [---]
[--] Week: [---] +26%
[--] Month: [-----] +46%
[--] Months: [------] -13%
[--] Year: [------] +8.50%
1-Year High: [---] on 2025-06-27
1-Year Low: [--] on 2025-12-21

Mentions by network (24h): Reddit: [--] TikTok: [--] YouTube: [--] X: [---]

Creators: [---] (24h)

Creators Line Chart
Creators 24-Hour Time-Series Raw Data
[---] unique social accounts have posts mentioning Vertex Pharmaceuticals Incorporated (VRTX) in the last [--] hours which is down 0.84% from [---] in the previous [--] hours Daily Average: [---]
[--] Week: [---] +7.10%
[--] Month: [---] +35%
[--] Months: [-----] +2.30%
[--] Year: [-----] +59%
1-Year High: [---] on 2025-06-27
1-Year Low: [--] on 2025-12-21

The most influential creators that mention Vertex Pharmaceuticals Incorporated in the last [--] hours

Creator Rank Followers Posts Engagements
@OracleEarnings [--] [------] [--] [---]
@semodough [--] [------] [--] [---]
@RNAiAnalyst [--] [------] [--] [---]
@WJones_Global [--] [---] [--] [---]
@AIStockSavvy [--] [------] [--] [---]
@tenet_research [--] [-------] [--] [---]
@doepke_michel [--] [-----] [--] [---]
@somoscdi [--] [------] [--] [---]
@MarcJacksonLA [--] [-----] [--] [---]
@HedgeFundTips [--] [------] [--] [---]

View More

Sentiment: 72%

Sentiment Line Chart
Sentiment 24-Hour Time-Series Raw Data
Current Value: 72%
Daily Average: 71%
[--] Week: 88% +26%
[--] Month: 61% -6%
[--] Months: 61% -9%
[--] Year: 61% -18%
1-Year High: 97% on 2025-07-18
1-Year Low: 44% on 2025-05-03

Most Supportive Themes:

  • Bullish Sentiment and Price Predictions: (45%) Users are expressing optimism about VRTX's future performance and predicting price increases.
  • Positive News and Partnerships: (25%) Recent developments such as reimbursement agreements and new collaborations are contributing to positive sentiment.
  • Technical Analysis and Chart Patterns: (15%) Analysis of VRTX's stock chart indicates bullish patterns, suggesting a potential upward trend.

Most Critical Themes:

  • Market Volatility: (10%) General concerns about the broader market's fluctuations and potential price corrections are present.
  • Token Closure Concerns: (5%) Some discussion revolves around the closure of a token, leading to negative sentiment.

Social Dominance: 0.03%

Social Dominance Line Chart
Social Dominance 24-Hour Time-Series Raw Data
Current Value: 0.03%
Daily Average: 0.047%
[--] Week: 0.025% +0.018%
[--] Month: 0.056% +0.027%
[--] Months: 0.056% -0.0051%
[--] Year: 0.056% -0.027%
1-Year High: 0.136% on 2025-03-12
1-Year Low: 0.015% on 2025-12-21

Market Dominance: 0.142%

Market Dominance Line Chart
Market Dominance 24-Hour Time-Series Raw Data
Current Value: 0.142%
Daily Average: 4%
1-Year High: 5.60% on 2026-02-06
1-Year Low: 0.142% on 2026-02-14

Market Cap: $125,479,413,406

Market Cap Line Chart
Market Cap 24-Hour Time-Series Raw Data
Current Value: $125,479,413,406
Daily Average: $114,185,675,807
[--] Week: $125,479,413,406 +4.10%
[--] Month: $124,695,193,872 +11%
[--] Months: $124,695,193,872 +24%
[--] Year: $124,695,193,872 +5.80%
1-Year High: $131,932,122,793 on 2025-03-17
1-Year Low: $93,977,429,218 on 2025-08-08

Top Vertex Pharmaceuticals Incorporated Social Posts

Top posts by engagements in the last [--] hours

Showing a maximum of [--] top social posts without a LunarCrush subscription.

"@Investingcom For long-term biotech holds consider $REGN with diversified pipeline beyond Eylea or $VRTX with cystic fibrosis dominance expanding into new indications"
X Link @PharmaAlerts 2026-02-14T18:45Z [---] followers, [---] engagements

"$MSTR 126% wild spike from bottom entry $AMD $NVDA $SMH $TSM $INTC $SPY $QQQ $BTC $ETH $MSTR $MARA $RIOT $HUT $AMAT $CRWD $LI $RIVN $NIO $COIN $AVGO $DOGE $AMC $CVNA $ASML $ADI $AMC $GME $SMCI $VRTX $LOVE $LLY $MELI $TQQQ $SPX $SWTX $ $tSLA 417% Ill rest my case here $AMD $NVDA $SMH $TSM $INTC $SPY $QQQ $BTC $ETH $MSTR $MARA $RIOT $HUT $AMAT $CRWD $LI $RIVN $NIO $COIN $AVGO $DOGE $AMC $CVNA $ASML $ADI $AMC $GME $SMCI $VRTX $LOVE $LLY $MELI $TQQQ $SPX $SWTX $ https://t.co/VxP7hrHqe0 $tSLA 417% Ill rest my case here $AMD $NVDA $SMH $TSM $INTC $SPY $QQQ $BTC $ETH $MSTR $MARA $RIOT $HUT $AMAT"
X Link @sMoontrade 2026-02-14T18:04Z [---] followers, [---] engagements

"forward p/e 2/13 yahoo finance $FIX [-----] $FTAI [-----] $STT [-----] $TDY [-----] $Q [-----] $NVT [-----] $ENTG [-----] $MTSI [-----] $AKAM [-----] $KRMN [------] $NVMI [-----] $DY [-----] $SOLS [-----] $VRTX [-----] $MOD [-----] $STRL [-----] $AEIS [-----] $SWKS [-----] $QRVO [-----] $POWL 38.31"
X Link @yukkeyo 2026-02-14T15:02Z [---] followers, [---] engagements

"If I am right and the new $RIG can generate $3B of annual free cash flow in a base case and $46B in an optimistic case a rerating is possible. There are not many companies in the world that can produce that level of free cash flow. Look at $UBER $AMT $AMD $VRTX $MMM. They trade between $90B and $300B market caps. But offshore is hated. It cannot get premium multiples. I think that is fine. On the Q3 [----] earnings call the CFO said: Once leverage is reduced management intends to return capital primarily through share repurchases rather than dividends. A lower multiple means they can buy back"
X Link @cannibalstocks 2026-02-14T07:14Z [---] followers, [----] engagements

Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing

Vertex Pharmaceuticals Incorporated (VRTX)
/topic/vertex-pharma